InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Ultragenyx Pharmaceutical Inc.

RARE Clue Score44
United States Fiscal year ends December CIK 0001515673 Results filed 3 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

15
Insider
Date
Role
Action
Shares
Price
Amount
Theodore Alan Huizenga
15 Sep 2026
SVP, Chief Accounting Officer
Sold on a plan
1,283
$13.57
$17.41K
Howard Horn
3 Aug 2026
Chief Financial Officer
Sold on a plan
4,696
$24.92
$117.02K
Karah Herdman Parschauer
3 Aug 2026
EVP and Chief Legal Officer
Sold on a plan
1,900
$24.92
$47.35K
Howard Horn
1 Jul 2026
Chief Financial Officer
Sold on a plan
4,698
$33.13
$155.64K
Karah Herdman Parschauer
15 Jun 2026
EVP and Chief Legal Officer
Sold on a plan
1,899
$24.62
$46.75K
Howard Horn
1 Jun 2026
Chief Financial Officer
Sold on a plan
4,653
$23.77
$110.60K
Shehnaaz Suliman
18 May 2026
Director
Sold on a plan
5,740
$25.12
$144.19K
Howard Horn
1 May 2026
Chief Financial Officer
Sold on a plan
4,683
$24.90
$116.61K
Howard Horn
1 Apr 2026
Chief Financial Officer
Sold on a plan
4,683
$20.97
$98.20K
Howard Horn
3 Mar 2026
Chief Financial Officer
Sold on a plan
1,635
$22.40
$36.62K
Howard Horn
2 Mar 2026
Chief Financial Officer
Sold on a plan
3,119
$22.54
$70.30K
Howard Horn
2 Mar 2026
Chief Financial Officer
Sold on a plan
5,290
$22.80
$120.61K
Howard Horn
2 Feb 2026
Chief Financial Officer
Sold on a plan
3,061
$23.56
$72.12K
Howard Horn
2 Jan 2026
Chief Financial Officer
Sold on a plan
3,150
$22.84
$71.95K
Howard Horn
10 Dec 2025
Chief Financial Officer
Sold on a plan
3,081
$36.38
$112.09K
Show all 28 transactions →

What was left out

Form 4 filings counted 40
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 0
Sales at will 13
Transactions with no price 0
Shares from compensation/vesting 459,777
History held since 3 Feb 2014